Additional evidence supporting its role in AD includes the observation that certain brain regions enriched in choline acetyltransferase, a biomarker for early detection of AD, also have high levels of KGDHC and are sensitive to KGDHC defects (Calingasan et al. 1994; Kim et al. 2006). The gene discussed is CHAT; the disease is Alzheimer disease.